Oncological hyperthermia, a key complement in cancer treatment

Sant Joan d’Alacant Hospital analyzes this technique that increases tumor cell sensitivity to conventional treatments.

Generic image of a medical thermometer showing a slightly elevated temperature.
AI

Generic image of a medical thermometer showing a slightly elevated temperature.

The Sant Joan d’Alacant University Hospital hosted on November 13th the conference ‘Oncological Hyperthermia: The forgotten fourth pillar of oncological treatment’, where this technique was analyzed as a complement to conventional treatments.

The session, led by Dr. Marina Arangüena, a specialist from the Catalan Institute of Oncology (ICO) in Barcelona, provided insights into the fundamentals of hyperthermia, its therapeutic possibilities, and the current state of its application in oncology. Oncological hyperthermia involves controllably raising the temperature of a body area to induce changes in tumor cells and increase their sensitivity to other cancer treatments.
This technique can act as a complement to conventional therapies such as chemotherapy and radiotherapy. Currently, its potential combination with immunotherapy is also being investigated. Dr. Arangüena emphasized that hyperthermia is "another tool in the service of oncological treatment aimed at sensitizing tumor cells to conventional treatments," and stressed that "it is not a substitute for conventional therapies," which must continue to form the basis of disease management.
Arangüena also presented results observed in specific clinical contexts, noting that hyperthermia can improve local disease control when combined with other treatments, although its potential benefits depend on the tumor type and clinical context. The available scientific evidence on its association with radiotherapy and studies on its combination with chemotherapy were reviewed.
The conference included an explanation of how hyperthermia works, the available technologies, a review of scientific evidence, clinical trial results, and recommendations from international guidelines. The status of this technique in Spain and its level of implementation were also discussed.
Finally, the experience of the Catalan Institute of Oncology was shared, where hyperthermia is available in three centers and its activity is currently centralized at the ICO L’Hospitalet center, offering a perspective on the application of this tool within a public health system.
Based on information from the official source: Departament de Salut Alacant-Sant Joan (18/11/2026)